← Evidence map

ReviewBiologics : targets & therapy2014

Resistant mutations in CML and Ph(+)ALL - role of ponatinib.

Geoffrey D Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

65 papers cite itlatest 60 shown

2014
…
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25349473